These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7480531)
1. Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo. Laakman G; Faltermaier-Temizel M; Bossert-Zaudig S; Baghai T; Lorkowski G Psychopharmacology (Berl); 1995 Jul; 120(1):109-15. PubMed ID: 7480531 [TBL] [Abstract][Full Text] [Related]
2. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder. Cohn JB; Wilcox CS Pharmacotherapy; 1984; 4(2):93-8. PubMed ID: 6144090 [TBL] [Abstract][Full Text] [Related]
3. A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression. Singh AN; Nair NP; Suranyi-Cadotte B; Schwartz G; Lizondo E Can J Psychiatry; 1988 Apr; 33(3):218-22. PubMed ID: 3289717 [TBL] [Abstract][Full Text] [Related]
4. Alprazolam and amitriptyline in the treatment of moderate depression. Lapierre YD; Browne M; Oyewumi K; Sarantidis D Int Clin Psychopharmacol; 1994; 9(1):41-5. PubMed ID: 8195582 [TBL] [Abstract][Full Text] [Related]
5. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods. Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245 [TBL] [Abstract][Full Text] [Related]
6. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients. Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581 [TBL] [Abstract][Full Text] [Related]
7. Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression. Rickels K; Feighner JP; Smith WT Arch Gen Psychiatry; 1985 Feb; 42(2):134-41. PubMed ID: 2858187 [TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial. Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097 [TBL] [Abstract][Full Text] [Related]
9. Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients. Ansseau M; von Frenckell R; Mertens C; de Wilde J; Botte L; Devoitille JM; Evrard JL; De Nayer A; Darimont P; Dejaiffe G Psychopharmacology (Berl); 1989; 98(2):163-8. PubMed ID: 2569214 [TBL] [Abstract][Full Text] [Related]
10. Novel Augmentation Strategies in Major Depression. Martiny K Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173 [TBL] [Abstract][Full Text] [Related]
11. Alprazolam compared to amitriptyline in the treatment of major depression. Eriksson B; Nagy A; Starmark JE; Thelander U Acta Psychiatr Scand; 1987 Jun; 75(6):656-63. PubMed ID: 3618289 [TBL] [Abstract][Full Text] [Related]
12. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. Fawcett J; Edwards JH; Kravitz HM; Jeffriess H J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312 [TBL] [Abstract][Full Text] [Related]
13. Alprazolam and amitriptyline in the treatment of major depressive disorder: a double-blind clinical and sleep EEG study. Hubain PP; Castro P; Mesters P; De Maertelaer V; Mendlewicz J J Affect Disord; 1990 Jan; 18(1):67-73. PubMed ID: 2136871 [TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression. Bremner JD J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of lesopitron in outpatients with generalized anxiety disorder. Fresquet A; Sust M; Lloret A; Murphy MF; Carter FJ; Campbell GM; Marion-Landais G Ann Pharmacother; 2000 Feb; 34(2):147-53. PubMed ID: 10676820 [TBL] [Abstract][Full Text] [Related]
16. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial. Wheatley D Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():77-80. PubMed ID: 9342764 [TBL] [Abstract][Full Text] [Related]
17. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Smith WT; Glaudin V; Panagides J; Gilvary E Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. Lydiard RB; Rickels K; Herman B; Feltner DE Int J Neuropsychopharmacol; 2010 Mar; 13(2):229-41. PubMed ID: 19737439 [TBL] [Abstract][Full Text] [Related]
19. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. Lydiard RB; Ballenger JC; Rickels K J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043 [TBL] [Abstract][Full Text] [Related]
20. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study]. Bernardi F; Fossi L; Faravelli C; Corsini GU; Varricchio MC Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]